Freedom Capital Markets has initiated coverage on Alphatec Holdings Inc (ATEC) with a Buy rating, marking the firm's first assessment of the company. This decision comes as Alphatec continues to innovate in the health care sector, focusing on spinal fusion technology products for the treatment of spinal disorders.
Headquartered in Carlsbad, California, Alphatec Holdings engages in the design, development, and marketing of solutions aimed at improving surgical outcomes for spinal disorders. The company has a market capitalization of $3.1 billion and currently employs 867 full-time staff. Its Organic Innovation Machine is dedicated to advancing technology that integrates with the Alpha InformatiX (AIX) Platform, enhancing the surgical experience.
As of December 10, 2025, the stock is priced at $20.79. Upcoming earnings reports are anticipated on February 23, 2026, and April 27, 2026, with estimated EPS of -$0.12 and -$0.18, respectively. Analysts have a consensus rating of Buy on the stock, with 4 Strong Buy, 12 Buy, and 2 Hold ratings, reflecting positive sentiment about the company's growth prospects.
Analyst ratings serve as professional opinions based on extensive research and financial models. While they can provide valuable insights, investors are advised to consider a range of factors, including company fundamentals and market trends, when making investment decisions. Analyst views may evolve over time as new information emerges.